Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
130.88 | -9.8% | 3.42% | 331,493.69 | 2.34% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
121.66 | 18.34% | 40.96% | 188,601.59 | 2.01% | 15.98% |
|
SWX:NOVN
Novartis
|
92.62 | 9.02% | 22.51% | 188,982.44 | 3.54% | 4.67% |
|
NYSE:PFE
Pfizer
|
28.92 | 7.37% | 37.31% | 163,877.87 | 5.83% | -9.31% |
|
LSE:GSK
GSK
|
17.84 | 6.89% | 22.64% | 72,731.8 | 3.2% | 0.79% |
|
NYSE:BAX
Baxter International Inc
|
35.17 | 83.19% | 110.83% | 17,921.94 | 3.27% | -3.14% |
|
NasdaqGS:SRPT
Sarepta Therapeutics
|
132.74 | 0% | 0% | 12,505.49 | 0% | 0% |
|
NYSE:PRGO
Perrigo Co PLC
|
30.10 | 35.17% | 58.31% | 4,186.4 | 3.65% | -10.73% |
|
XTRA:MDG1
Medigene
|
1.42 | 0% | 0% | 37.46 | 0% | 0% |
